Expert Consultations: Real-World Answers

Broad Spectrum Micronutrients in Psychiatry – Interview

Published on November 1, 2023 Certification expiration date: November 1, 2026

Guest

Radwa Hanafy

To unlock this audio you need to become a Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Member.

Check Our CME Program

Downloads for Offline Access

Download Audio File (MP3)

Interview Highlights

Broad-spectrum micronutrients (BSMs) may be considered as a second- or third-line agent for the management of ADHD; they have also been found to be helpful for the management of emotion dysregulation.
Although a trial of broad-spectrum micronutrients may be justifiable given its safety, cost, and potential benefits, initiating BSMs begins with a discussion of patient preferences and goals.

Text Version

This edition of Psychopharmacology Institute’s Expert Consultations features Amelia Villagomez, M.D., Adjunct Clinical Assistant Professor of psychiatry at the University of Arizona. In this interview, we will discuss broad-spectrum micronutrients (BSMs) in Psychiatry.

Radwa Hanafy, M.D.: Hello and welcome back to the Psychopharmacology Institute. You are listening to Expert Consultations, where we meet with experts to discuss clinically relevant topics and

Unlock this Expert Consultation and earn 0.50 CMEs
Become a Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Member.

Get Instant Access

Already have an account? Sign in

Learning Objectives:

Discuss the concepts behind broad-spectrum micronutrient (BSM) supplementation.
Identify patients who may be suitable candidates for BSM supplementation.
Evaluate research on the efficacy of BSM supplementation in the management of selected psychiatric conditions.

Original Release Date: November 1, 2023

Review and Re-release Date: March 1, 2024

Expiration Date: November 1, 2026

Expert: Amelia Villagomez, M.D.

Medical Editors: Radwa Hanafy, M.D., Melissa Mariano, M.D.

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@ml-prod.psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Answer the quiz for promoting retention of knowledge.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Amelia Villagomez, M.D.